| Animal models of nonalcoholic fatty liver disease L Hebbard, J George Nature reviews Gastroenterology & hepatology 8 (1), 35-44, 2011 | 544 | 2011 |
| T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model LW Hebbard, M Garlatti, LJT Young, RD Cardiff, RG Oshima, B Ranscht Cancer research 68 (5), 1407-1416, 2008 | 191 | 2008 |
| Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells X Huo, S Han, G Wu, O Latchoumanin, G Zhou, L Hebbard, J George, ... Molecular cancer 16 (1), 1-10, 2017 | 143 | 2017 |
| Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? D van der Poorten, CF Samer, M Ramezani‐Moghadam, S Coulter, ... Hepatology 57 (6), 2180-2188, 2013 | 142 | 2013 |
| CD44 expression and regulation during mammary gland development and function L Hebbard, A Steffen, V Zawadzki, C Fieber, N Howells, J Moll, H Ponta, ... Journal of cell science 113 (14), 2619-2630, 2000 | 102 | 2000 |
| Multifaceted roles of adiponectin in cancer L Hebbard, B Ranscht Best practice & research Clinical endocrinology & metabolism 28 (1), 59-69, 2014 | 100 | 2014 |
| Aptamers: A promising chemical antibody for cancer therapy G Zhou, G Wilson, L Hebbard, W Duan, C Liddle, J George, L Qiao Oncotarget 7 (12), 13446, 2016 | 97 | 2016 |
| Increased expression of H/T-cadherin in tumor-penetrating blood vessels L Wyder, A Vitaliti, H Schneider, LW Hebbard, DR Moritz, M Wittmer, ... Cancer research 60 (17), 4682-4688, 2000 | 95 | 2000 |
| Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo LW Hebbard, J Maurer, A Miller, J Lesperance, J Hassell, RG Oshima, ... Cancer research 70 (21), 8863-8873, 2010 | 83 | 2010 |
| Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer MS Denzel, LW Hebbard, G Shostak, L Shapiro, RD Cardiff, B Ranscht Clinical Cancer Research 15 (10), 3256-3264, 2009 | 83 | 2009 |
| Embelin Reduces Colitis-Associated Tumorigenesis through Limiting IL-6/STAT3 SignalingEmbelin Reduces Colitis-Associated Tumorigenesis Y Dai, H Jiao, G Teng, W Wang, R Zhang, Y Wang, L Hebbard, J George, ... Molecular cancer therapeutics 13 (5), 1206-1216, 2014 | 79 | 2014 |
| The role of fructose in metabolism and cancer B Charrez, L Qiao, L Hebbard Hormone molecular biology and clinical investigation 22 (2), 79-89, 2015 | 77 | 2015 |
| Angiogenic acceleration of Neu induced mammary tumor progression and metastasis RG Oshima, J Lesperance, V Munoz, L Hebbard, B Ranscht, N Sharan, ... Cancer research 64 (1), 169-179, 2004 | 71 | 2004 |
| Non-viral causes of liver cancer: does obesity led inflammation play a role? B Alzahrani, TJ Iseli, LW Hebbard Cancer letters 345 (2), 223-229, 2014 | 69 | 2014 |
| Role of adiponectin and its receptors in cancer S Obeid, L Hebbard Cancer biology & medicine 9 (4), 213, 2012 | 69 | 2012 |
| The role of micronutrients in the infection and subsequent response to hepatitis C virus S Gupta, SA Read, NA Shackel, L Hebbard, J George, G Ahlenstiel Cells 8 (6), 603, 2019 | 66 | 2019 |
| Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play B Charrez, L Qiao, L Hebbard World journal of gastroenterology 22 (8), 2494, 2016 | 61 | 2016 |
| Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers G Zhou, O Latchoumanin, L Hebbard, W Duan, C Liddle, J George, L Qiao Advanced drug delivery reviews 134, 107-121, 2018 | 59 | 2018 |
| Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development CM Jiang, CW Pu, YH Hou, Z Chen, M Alanazy, L Hebbard World Journal of Gastroenterology: WJG 20 (44), 16464, 2014 | 56 | 2014 |
| Experimental nonalcoholic steatohepatitis compromises ureagenesis, an essential hepatic metabolic function KL Thomsen, H Grønbæk, E Glavind, L Hebbard, N Jessen, A Clouston, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 307 (3 …, 2014 | 56 | 2014 |
Christopher LiddleProfessor of Clinical Pharmacology and Hepatology, University of SydneyVerified email at sydney.edu.au
